Главная страница

Экстернализирующие расстройстваглаваД. 1


Скачать 0,86 Mb.
НазваниеЭкстернализирующие расстройстваглаваД. 1
АнкорD.1-ADHD_Russian-17.pdf
Дата20.05.2018
Размер0,86 Mb.
Формат файлаpdf
Имя файлаD_1-ADHD_Russian-17.pdf
оригинальный pdf просмотр
ТипДокументы
#71311
страница5 из 5
Каталогid21379412

С этим файлом связано 5 файл(ов). Среди них: M_A_Balakirev_quot_Romansy_i_pesni_quot.pdf, Dargomyzhskiy_-_Izbrannye_romansy_i_pesni.pdf, Gennadiy_Rozhdestvenskiy_Preambuly.pdf, D_1-ADHD_Russian-17.pdf, Raspevanie_na_urokakh_penia_i_v_detskom_khore_nachalnoy_shkoly.p.
Показать все связанные файлы
1   2   3   4   5
, CD005648.
Elia J, Vetter VL (2010). Cardiovascular effects of medications for the treatment of attention-deficit hyperactivity disorder: what is known and how should it influence prescribing in children?
Paediatric Drugs, 12:165-175.
Fabiano GA, Pelham WE, Coles EK et al (2009). A meta-analysis of behavioral treatments for attention-deficit/hyperactivity disorder. Clinical Psychology Review, 29:129-140.
Faraone SV, Biederman J, Mick E (2006). The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychological Medicine, 36:159-165.
Faraone SV, Buitelaar J (2010). Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis.
European Child & Adolescent Psychiatry, 19:353-364.
Faraone SV, Glatt SJ (2010). A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta- analysis of effect sizes. Journal of Clinical Psychiatry, 71:754-
763.
Faraone SV, Perlis RH, Doyle AE et al (2005). Molecular genetics of attention-deficit/hyperactivity disorder. Biological Psychiatry,
57:1313-1323.
Faraone SV, Wilens TE (2007). Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion.
Journal of clinical Psychiatry, 68 (sup 11):15-22.

24
ADHD D.1
IACAPAP Textbook of Child and Adolescent Mental Health
Gapin JI, Labban JD, Etnier JL (2011). The effects of physical activity on attention deficit hyperactivity disorder symptoms: the evidence. Preventive Medicine, 52 (supp 1):S70-S74.
Hack M, Youngstrom EA, Cartar L et al (2004). Behavioral outcomes and evidence of psychopathology among very low birth weight infants at age 20 years. Pediatrics,114:932-940.
Halperin JM. Healey DM (2011). The influences of environmental enrichment, cognitive enhancement, and physical exercise on brain development: can we alter the developmental trajectory of ADHD? Neuroscience and Biobehavioral Reviews, 35:621-
634.
Hazell PL, Kohn MR, Dickson R et al (2011). Core ADHD Symptom improvement with atomoxetine versus methylphenidate: a direct comparison meta-analysis. Journal of Attention
Disorders, 15:1557-1246.
Hohman LB (1922). Post-encephalitic behavior disorder in children.
Johns Hopkins Hospital Bulletin, 33:89-97.
Kahn E, Cohen L (1934). Organic drivenness: A brain stem syndrome and experience. New England Journal of Medicine, 210:748–
756.
Karpouzis F, Bonello R, Pollard H (2010). Chiropractic care for paediatric and adolescent Attention-Deficit/Hyperactivity
Disorder: A systematic review. Chiropractic & Osteopathy,
18:13.
http://www.biomedcentral.com/content/pdf/1746-
1340-18-13.pdf
Kessler RC, Adler LA, Barkley R et al (2005). Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication. Biological Psychiatry, 57:1442-1451.
Kieling C, Goncalves RR, Tannock R et al (2008). Neurobiology of attention deficit hyperactivity disorder. Child and Adolescent
Psychiatry Clinics of North America, 17:285-307, viii.
Krisanaprakornkit T, Ngamjarus C, Witoonchart C et al (2010).
Meditation therapies for attention-deficit/hyperactivity disorder (ADHD). Cochrane Database of Systematic Reviews,
CD006507.
Lahey BB, Willcutt EG (2010). Predictive validity of a continuous alternative to nominal subtypes of attention-deficit/
hyperactivity disorder for DSM-V. Journal of Clinical Child
and Adolescent Psychology, 39:761-775.
Langley K, Rice F, van den Bree MB et al (2005). Maternal smoking during pregnancy as an environmental risk factor for attention deficit hyperactivity disorder behaviour. A review.
Minerva Pediatrica, 57:359-371.
Lee SI, Schachar RJ, Chen SX et al (2008). Predictive validity of
DSM-IV and ICD-10 criteria for ADHD and hyperkinetic disorder. Journal of Child Psychology and Psychiatry, 49:70-78.
Li S, Yu B, Zhou D et al (2011). Acupuncture for Attention Deficit
Hyperactivity Disorder (ADHD) in children and adolescents.
Cochrane Database of Systematic Reviews, CD007839.
Linnet KM, Dalsgaard S, Obel C et al (2003). Maternal lifestyle factors in pregnancy risk of attention deficit hyperactivity disorder and associated behaviors: review of the current evidence.
American Journal of Psychiatry,160:1028-1040.
Mannuzza S, Klein RG, Bessler A et al (1997). Educational and occupational outcome of hyperactive boys grown up. Journal
of the American Academy of Child & Adolescent Psychiatry,
36:1222-1227.
Mannuzza S, Klein RG, Bessler A et al (1998). Adult psychiatric status of hyperactive boys grown up. American Journal of Psychiatry,
155:493-498.
Mannuzza S, Klein RG, Moulton JL (2003). Persistence of attention- deficit/hyperactivity disorder into adulthood: what have we learned from the prospective follow-up studies? Journal of
Attention Disorders, 7:93-100.
Mick E, Biederman J, Prince J et al (2002). Impact of low birth weight on attention-deficit hyperactivity disorder.
Journal of
Developmental & Behavioral Pediatrics, 23:16-22.
Molina BS, Hinshaw SP, Swanson JM et al (2009). The MTA at 8 years: prospective follow-up of children treated for combined-type
ADHD in a multisite study. Journal of the American Academy
of Child & Adolescent Psychiatry,48:484-500.
Neale BM, Medland SE, Ripke S et al (2010). Meta-analysis of genome- wide association studies of attention-deficit/hyperactivity disorder. Journal of the American Academy of Child &
Adolescent Psychiatry, 49:884-897.
Nigg J, Nikolas M, Burt SA (2010). Measured gene-by-environment interaction in relation to attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and
Adolescent Psychiatry, 49:863-873.
World Health Organisation (1993). The ICD-10 Classification of Mental
and Behavioral Disorders: Diagnostic Criteria for Research,
Geneva: World Health Organisation.
Pelsser LM, Frankena K, Toorman J et al (2011). Effects of a restricted elimination diet on the behaviour of children with attention- deficit hyperactivity disorder (INCA study): a randomised controlled trial. Lancet, 377:494-503.
Pintov S, Hochman M, Livne A et al (2005). Bach flower remedies used for attention deficit hyperactivity disorder in children--a prospective double blind controlled study. European Journal
of Paediatric Neurology, 9:395-398.
Pliszka S (2007). Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child &
Adolescent Psychiatry, 46:894-921.
Polanczyk G, Caspi A, Houts R et al (2010). Implications of extending the ADHD age-of-onset criterion to age 12: results from a prospectively studied birth cohort. Journal of the American
Academy of Child & Adolescent Psychiatry, 49:210-216.
Polanczyk G, De Lima MS, Horta BL et al (2007). The worldwide prevalence of ADHD: a systematic review and metaregression analysis. American Journal of Psychiatry, 164:942-948.
Polanczyk G, Rohde LA, Szobot C et al (2008). ADHD treatment in
Latin America and the Caribbean. Journal of the American
Academy of Child and Adolescent Psychiatry, 47:721-2.
Rickson DJ (2006). Instructional and improvisational models of music therapy with adolescents who have attention deficit hyperactivity disorder (ADHD): a comparison of the effects on motor impulsivity. Journal of Music Therapy, 43:39-62.
Rohde LA (2008). Is there a need to reformulate attention deficit hyperactivity disorder criteria in future nosologic classifications? Child and Adolescent Psychiatry Clinics of North
America, 17:405-420, x.
Rohde LA, Biederman J, Zimmermann H et al (2000). Exploring
ADHD age-of-onset criterion in Brazilian adolescents.
European Child and Adolescent Psychiatry, 9:212-218.
Sciutto MJ, Eisenberg M (2007). Evaluating the evidence for and against the overdiagnosis of ADHD. Journal of Attention Disorders,
11:106-113.
Sharkey L, Fritzgerald M (2007). The History of attention deficit hyperactivity disorder. In: Fitzgerald M, Bellgrove M,Gill M
(eds.) Handbook of Attention Deficit Hyperactivity Disorder
(1st ed). West Sussex, England: John Wiley & Sons.
Shaw P, Eckstrand K, Sharp W et al (2007). Attention-deficit/
hyperactivity disorder is characterized by a delay in cortical maturation. Proceedings of the National Academy of Sciences U
S A, 104:19649-54.
Souza I, Pinheiro MA, Denardin D et al (2004). Attention-deficit/
hyperactivity disorder and comorbidity in Brazil: comparisons between two referred samples. European Child &
Adolescent Psychiatry, 13:243-248.
Stein MA (2008). Impairment associated with adult ADHD. CNS

25
ADHD D.1
IACAPAP Textbook of Child and Adolescent Mental Health
Spectrums, 13:9-11.
Stiefel G, Besag FM (2010). Cardiovascular effects of methylphenidate, amphetamines and atomoxetine in the treatment of attention-deficit hyperactivity disorder. Drug Safety, 33:821-
842.
Still G (1902). Some abnormal psychical conditions in children. Lancet,
1:1008-1012.
Swanson JM, Kinsbourne M, Nigg J et al (2007). Etiologic subtypes of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis. Neuropsychology Review, 17:39-59.
Taylor E, Sonuga-Barke E (2008). Disorders of attention and acitivity.
In: Rutter M, Bishop D, Pine D et al (eds.) Rutter's Child &
Adolescent Psychiatry 5th ed. Oxford: Wiley-Blackwell.
Weber W, Vander Stoep A, Mccarty RL et al (2008). Hypericum perforatum (St John's wort) for attention-deficit/
hyperactivity disorder in children and adolescents: a randomized controlled trial. Journal of the American Medical
Association, 299:2633-2641.
1   2   3   4   5

перейти в каталог файлов
связь с админом